Revolution Medicines Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

40.69

0.31 (0.77%)

At close: May 01, 2025, 3:59 PM

40.31

-0.93%

Pre-market: May 02, 2025, 05:08 AM EDT

Revolution Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-600.09M	-436.37M	-248.71M	-187.09M	-108.16M	-47.66M	-41.79M	-31.13M
Depreciation & Amortization	-43.5M	9.31M	9.66M	7.33M	6.54M	3.34M	1.76M	1.19M
Stock-Based Compensation	79.2M	61.77M	31.2M	20.72M	8.89M	3.16M	855K	141K
Other Working Capital	5.62M	864K	-22.03M	-1.66M	-8.61M	-14.09M	37.95M	2.68M
Other Non-Cash Items	6.55M	-18.13M	-2.64M	3.13M	1.34M	4.75M	2.12M	549K
Deferred Income Tax	n/a	-3.91M	-419K	n/a	-375K	-4.37M	201K	n/a
Change in Working Capital	406K	36.75M	-13.49M	8.72M	-8.3M	-8.83M	38.06M	4.65M
Operating Cash Flow	-557.44M	-350.57M	-224.4M	-147.18M	-100.06M	-49.62M	1.21M	-25.15M
Capital Expenditures	-10.31M	-7.73M	-10.82M	-6.53M	-2.93M	-2.59M	-1.5M	-1.57M
Cash Acquisitions	n/a	n/a	13.3M	135.59M	231.3M	196K	160K	n/a
Purchase of Investments	-2.14B	-1.06B	-612.77M	-671.34M	-544.13M	-172.27M	n/a	n/a
Sales Maturities Of Investments	1.59B	724.05M	599.47M	535.75M	312.83M	66.69M	n/a	n/a
Other Investing Acitivies	n/a	-1	-13.3M	-135.59M	-231.3M	6M	n/a	n/a
Investing Cash Flow	-554.39M	-342.6M	-24.12M	-142.12M	-234.23M	-101.97M	-1.34M	-1.57M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	3.32M	n/a	n/a	n/a	-45K	-131K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	113.06M	843.44M	3.39M	2.94M	2.71M	-1.37M	289K	22.66M
Financial Cash Flow	959.41M	1.23B	301.43M	294.18M	422.78M	98.66M	60.85M	22.66M
Net Cash Flow	-152.42M	536.03M	52.91M	4.88M	88.48M	-52.93M	60.72M	-4.06M
Free Cash Flow	-567.74M	-358.3M	-235.22M	-153.71M	-103M	-52.2M	-286K	-26.72M